Anxiety - Nursing Case Study

Pathophysiology

• Primary mechanism: Dysregulation of neurotransmitters, especially serotonin, norepinephrine, and gamma-aminobutyric acid (GABA), leads to heightened arousal and anxiety. Imbalances in these neurotransmitters disrupt normal communication between neurons, increasing anxiety symptoms.

• Secondary mechanism: Overactivity of the hypothalamic-pituitary-adrenal (HPA) axis results in excessive cortisol production. Chronic stress and anxiety increase cortisol levels, impairing feedback mechanisms and perpetuating the stress response.

• Key complication: Prolonged anxiety can lead to physical health issues, including cardiovascular disorders and a weakened immune response, due to sustained autonomic nervous system activation and elevated stress hormone levels.

Patient Profile

Demographics:

34-year-old female, high school teacher

History:

• Key past medical history: Generalized Anxiety Disorder diagnosed 3 years ago, mild asthma

• Current medications: Sertraline 50 mg daily, Albuterol inhaler as needed

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increased anxiety and difficulty concentrating over the past month

• Key symptoms: Restlessness, fatigue, occasional heart palpitations, frequent headaches

• Vital signs: Blood pressure 142/88 mmHg, heart rate 98 bpm, respiratory rate 20 breaths per minute, temperature 98.6°F

Section 1

The initial assessment reveals that the patient's anxiety symptoms have been progressively intensifying despite adherence to her current medication regimen. She reports a significant impact on her daily functioning, including her ability to effectively manage her responsibilities as a teacher. During the examination, she appears visibly tense and exhibits a fine tremor in her hands. Her heart rate remains elevated at 98 bpm, and her blood pressure has increased slightly to 146/90 mmHg, suggesting a stress-related response rather than a primary cardiovascular issue. Her respiratory rate is slightly increased, indicating mild hyperventilation, which may be contributing to her frequent headaches.

Further investigation through laboratory tests shows slightly elevated cortisol levels, confirming the suspicion of HPA axis dysregulation. Additionally, her thyroid function tests are within normal limits, ruling out hyperthyroidism as a contributing factor to her symptoms. The patient's complete blood count and metabolic panel are unremarkable, indicating no acute physiological disturbances. However, it's noted that her serum magnesium level is at the lower end of the normal range, which could potentially exacerbate anxiety symptoms and warrant monitoring.

Given these findings, the clinical team considers adjusting her treatment plan to address both the neurotransmitter imbalance and the overactivity of the HPA axis. This may include increasing the dose of Sertraline or considering an adjunct therapy such as cognitive-behavioral therapy (CBT) to enhance coping mechanisms and stress management. Additionally, patient education on lifestyle modifications, such as engaging in regular physical activity and mindfulness practices, is emphasized to reduce overall stress levels and improve her ability to manage anxiety symptoms. The patient's response to these interventions will be closely monitored to assess their effectiveness and to identify any emerging complications or need for further adjustments in her care plan.

Section 2

Several weeks after implementing the adjusted treatment plan, the patient returns for a follow-up appointment. During this visit, she reports a modest improvement in her anxiety levels, particularly noting fewer instances of debilitating panic during her workday. However, she continues to experience episodes of heightened anxiety in the mornings, which have resulted in occasional lateness to her job. Upon further examination, her heart rate has decreased slightly to 90 bpm, and her blood pressure has stabilized at 138/88 mmHg. These changes suggest a partial reduction in her stress response. Yet, she continues to exhibit signs of tension, such as a persistent fine tremor and intermittent headaches, particularly in the afternoons.

The patient has been engaging in cognitive-behavioral therapy sessions regularly, and her therapist reports that she is beginning to develop more effective coping strategies. Despite this progress, her cortisol levels remain elevated, as revealed by a follow-up laboratory test. This persistent HPA axis hyperactivity raises concerns about underlying factors that may be sustaining her stress response. The clinical team decides to introduce a low-dose beta-blocker to help manage the physiological symptoms of anxiety, such as tremors and elevated heart rate, while continuing to monitor her response to this pharmacological addition.

Meanwhile, the patient has been encouraged to maintain her lifestyle modifications, including regular physical activity and mindfulness practices. She acknowledges the positive influence these changes have had on her overall well-being, though she admits to difficulty maintaining consistency due to her demanding teaching schedule. The team plans to reassess her response to the combined therapeutic approach in another month, with an emphasis on further exploring any barriers to her full recovery and considering additional interventions if necessary. This ongoing evaluation will help ensure the patient's treatment plan remains dynamic and responsive to her evolving needs.

Section 3

Several weeks after the introduction of the low-dose beta-blocker, the patient returns for a reassessment. She expresses a noticeable reduction in her physical symptoms of anxiety, such as the fine tremor and rapid heart rate, which have become less pronounced. However, it becomes apparent during the consultation that her psychological symptoms, particularly her morning anxiety, have not improved significantly. She continues to struggle with initiating her day, which impacts her punctuality and overall productivity at work. Despite these challenges, she reports feeling more equipped to manage acute anxiety episodes due to the coping strategies learned in her therapy sessions.

Upon examination, her vital signs show a further stabilized heart rate at 82 bpm and a slight decrease in blood pressure to 130/84 mmHg, suggesting a positive response to the beta-blocker. However, her recent lab results reveal that her cortisol levels, while slightly reduced, remain above the normal range. This persistent elevation suggests an ongoing HPA axis dysregulation, which may be perpetuated by underlying stressors not yet fully addressed. Further discussions with the patient reveal significant work-related stressors, including increased workload demands and insufficient support at her school, which may be contributing to her sustained anxiety and elevated cortisol levels.

In light of these findings, the clinical team decides to incorporate a targeted stress-reduction intervention focused on time management and workplace stress. This plan includes the introduction of brief, structured mindfulness exercises to be performed during work breaks and a referral to a stress management workshop tailored for educators. The team also considers the possibility of adjusting her beta-blocker dosage if her physical symptoms continue to respond favorably. The patient is scheduled for another follow-up in a month to evaluate the effectiveness of these new interventions and to further fine-tune her treatment plan based on her evolving needs.

Section 4

Several weeks after implementing the stress-reduction intervention, the patient returns for her scheduled follow-up appointment. During this visit, she reports some progress with managing her workplace stress. She has been consistently practicing the mindfulness exercises during her breaks, which she finds helpful in reducing her immediate feelings of tension. However, she notes that while her morning anxiety has slightly improved, it remains a significant challenge. She continues to experience difficulty in starting her day, which occasionally impacts her punctuality, though her overall productivity has seen a slight uptick.

Upon reassessment, her vital signs remain stable with a heart rate of 80 bpm and blood pressure at 128/82 mmHg, indicating continued positive response to the beta-blocker. Encouragingly, her most recent lab results show a further decrease in cortisol levels, though they are still marginally elevated. Despite these improvements, the patient mentions a new development: she has been experiencing intermittent headaches, particularly in the afternoons. These headaches are described as tension-like, without any accompanying visual disturbances or nausea.

Given these findings, the clinical team considers several possibilities. The headaches may be a response to the persistent stress, a side effect of her current medication regimen, or possibly linked to her elevated cortisol levels. The team decides to conduct a more thorough neurological assessment and review her medication dosage to determine if adjustments are necessary. Additionally, they explore the option of incorporating relaxation techniques specifically targeting headache management into her intervention plan. The patient is advised to keep a headache diary to track the frequency and severity of her headaches, which will be useful in refining her treatment approach at the next follow-up.

Section 5

During the neurological assessment, the patient exhibits no signs of focal neurological deficits, and her cognitive function appears intact. However, she reports increased muscle tension in her neck and shoulders, which aligns with her tension-type headache description. The clinical team conducts a thorough medication review, focusing on her beta-blocker dosage, as it can sometimes contribute to headaches. Additionally, the team considers her recent lifestyle changes, including increased screen time at work due to heightened productivity, which might be contributing to her symptoms.

New diagnostic results reveal that while her cortisol levels have decreased further, they still hover above the normal range, suggesting ongoing stress. Notably, her serum magnesium levels are slightly lower than the reference range, potentially exacerbating her headache symptoms. Given these findings, the team decides to introduce magnesium supplements to her regimen and advises her to increase hydration and maintain a balanced diet rich in magnesium-rich foods. They also emphasize the importance of ergonomic adjustments at her workstation to alleviate muscle tension.

In response to these interventions, the patient is encouraged to continue her mindfulness exercises but with added focus on progressive muscle relaxation techniques targeting the neck and shoulder areas. She is also advised to implement regular breaks from screen time to reduce eye strain. As the patient begins incorporating these adjustments, she is encouraged to continue maintaining her headache diary, documenting any changes in frequency or intensity. This will aid the clinical team in evaluating the effectiveness of the interventions and making further adjustments at the next follow-up.